Finland· FI-REL-REL54202
Temybric Ellipta
A vilanterol, umeclidinium bromid und fluticason furoat product containing fluticasone furoate + umeclidinium bromide + vilanterol trifenate, registered in Finland by GlaxoSmithKline Trading Services Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Vilanterol, umeclidinium bromid und fluticason furoat is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AL08 (vilanterol, umeclidinium bromid und fluticason furoat), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Vilanterol, umeclidinium bromid und fluticason furoat · ATC R03AL08
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Fluticasone furoate + Umeclidinium bromide + Vilanterol trifenate
- Manufacturer
- GlaxoSmithKline Trading Services Limited
- Country
- Finland (FI)
- ATC code
- R03AL08
- ATC class
- Vilanterol, Umeclidinium bromid und Fluticason furoat
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vilanterol, umeclidinium bromid und fluticason furoat in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomTrelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhalerGlaxoSmithKline UK Ltd
- SpainELEBRATO ELLIPTA 92 MICROGRAMOS/55 MICROGRAMOS/22 MICROGRAMOS POLVO PARA INHALACION (UNIDOSIS)Glaxosmithkline Trading Services Limited
- SwedenElebrato Ellipta 92 mikrogram/55 mikrogram/22 mikrogram Inhalationspulver, avdelad dosGlaxoSmithKline Trading Services Ltd
- SwitzerlandTrelegy Ellipta, Einzeldosiertes Pulver zur InhalationGlaxoSmithKline AG
- PolandElebrato ElliptaGlaxoSmithKline Trading Services Limited
- CanadaTRELEGY ELLIPTAGLAXOSMITHKLINE INC
- IrelandTrelegy Ellipta 92 micrograms/55 micrograms/22 micrograms inhalation powder, pre-dispensedGlaxoSmithKline Trading Services Limited
- NorwayTrelegy ElliptaGlaxoSmithKline Trading Services Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Elebrato Ellipta, Trelegy Ellipta
- Liechtenstein · Elebrato Ellipta, Trelegy Ellipta
- Norway · Elebrato Ellipta, Trelegy Ellipta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa98b26c-1a53-4d52-8c51-ec9b9a28a26c GET /v1/drugs/fa98b26c-1a53-4d52-8c51-ec9b9a28a26c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1",
"form": "inhalaatiojauhe, annosteltu",
"route": "Inhalaatioon",
"ddd_unit": "ED",
"strength": "92 mikrog / 55 mikrog / 22 mikrog",
"atc_label": "vilanteroli, umeklidiniumbromidi ja flutikasonifuroaatti",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/19/1378/001-003",
"fimea_rel_id": "REL54202",
"authorised_at": "2019-06-12"
}See everything about vilanterol, umeclidinium bromid und fluticason furoat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.